WVXU: FDA says decongestant in over-the-counter cold medicines doesn't work
An advisory panel to the Food and Drug Administration agreed unanimously last month that an ingredient found in many over-the-counter cold medicines called phenylephrine doesn't work to clear nasal congestion when taken orally.
Ahmad Sedaghat, MD, PhD, director of the Division of Rhinology, Allergy and Anterior Skull Base Surgery at the University of Cincinnati's College of Medicine and a UC Health physician, and Michael Hegener, PharmD, associate professor of pharmacy at UC's James L. Winkle College of Pharmacy, joined WVXU's Cincinnati Edition to discuss the recent announcement.
Hegener explained phenylephrine is a decongestant that works by shrinking blood vessels in the nose, which opens up the nasal cavities and helps people breathe easier. Many drug companies replaced the drug pseudoephedrine with phenylephrine in their over the counter products after federal legislation made it harder to access pseudoephedrine because it can be used to make methamphetamines.
Hegener noted the FDA recommendation was for oral tablet products that contain phenylephrine, not nasal sprays.
"The effectiveness of the nasal spray has been established more firmly and that’s not what’s up for debate today," Hegener said. "It’s the oral form that everyone is talking about."
Sedaghat said oftentimes cold medicines have a combination of active drugs in them, so consumers may not want to throw away products with phenylephrine because the other ingredients could still be helpful.
"One thing that I’ve also recommended to patients to do is to look at their favorite cold medication and see what the active ingredients are in that medication, and because that cold medication will potentially have had other ingredients that will not get pulled off of shelves, the patients can go ahead and get the other medications that are in their favorite combination cold medicine," he said.
While effective, Sedaghat said the nasal sprays can raise blood pressure and become addictive, so patients are advised to use the spray no more than two to three days in a row. Patients can also seek out saline rinses to help clear congestion, he said.
Listen to the Cincinnati Edition segment.
Featured photo at top of a man sneezing. Photo/dragana991/iStock.
Related Stories
Bono, Chris Tucker Visit UC To Discuss Africa
December 5, 2002
U2's Bono and comedian-actor Chris Tucker led a delegation from the DATA organization who came to UC to talk about potentially catastrophic problems in Africa.
New Year's Help for Those Looking to Kick the Habit
December 20, 2002
Quitting smoking consistently ranks among the top three resolutions made by New Year's resolvers each year.
E-BRIEF: Let's Toast to a Healthier 2003
January 8, 2003
The New Year often means a new health kick: Vows to tone up and trim down, and maybe going to the doctor and getting ourselves as regularly "maintenanced" as we do our cars. So, this week's University of Cincinnati e-briefing examines the health concerns of the young and old, and what you should be doing to preserve your good health.
Today's ML King Events: One On, One Off
January 8, 2003
A memorial march, presentations, poetry and dance will pay tribute to the slain civil rights leader.
UC Named Lead Organization for OSHA Training Consortium
January 13, 2003
UC Continuing Medical Education (CME) has been selected as the lead organization for the Occupational Safety and Health Administration (OSHA) Great Lakes Training Consortium by the U.S. Department of Labor.
Ignorance of Stroke s Warning Signs a Barrier to Treatment; More Education Needed, UC Researchers Report in JAMA
January 13, 2003
Demographic groups facing the greatest risk of death and disability from stroke are the least likely to recognize stroke s warning signs and risk factors, according to a study by UC researchers published in the January 15 issue of the Journal of the American Medical Association (JAMA).
Ignorance of Stroke s Warning Signs a Barrier to Treatment; More Education Needed, UC Researchers Report in JAMA
January 14, 2003
Demographic groups facing the greatest risk of death and disability from stroke are the least likely to recognize stroke s warning signs and risk factors, according to a study by UC researchers published in the January 15 issue of the Journal of the American Medical Association (JAMA).
UC Researchers Find New Link Between the Eye and the Clock in the Brain
January 20, 2003
Results of a study done by a team of researchers working in the laboratories of Michael Lehman, PhD, professor, Department of Cell Biology, Neurobiology, and Anatomy at the UC College of Medicine, will appear in the February issue of Nature Neuroscience.
UC Researchers Find New Link Between the Eye and the Clock in the Brain
January 21, 2003
Results of a study done by a team of researchers working in the laboratories of Michael Lehman, PhD, professor, Department of Cell Biology, Neurobiology, and Anatomy at the UC College of Medicine, will appear in the February issue of Nature Neuroscience.
Leader of Fetal Surgery to Deliver Lectures at UC
January 31, 2003
An internationally recognized authority on fetal surgery will lecture at the UC Medical Center, representing the first of a series of lectures on fetal surgery presented by the department of Obstetrics and Gynecology (Ob/Gyn).